R
RPTX
Repare Therapeutics Inc.
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
TipRanks·01/28 22:32
Repare Therapeutics completes acquisition and goes private
Dow Jones·01/28 22:08
*News On Repare Therapeutics Inc. (RPTX) Now Under XEN.XX
Reuters·01/28 22:01
Repare Therapeutics Completes Acquisition by XenoTherapeutics
Reuters·01/16 22:11
Repare Therapeutics Shareholders Approve Acquisition by XenoTherapeutics
Reuters·01/16 21:58
Repare Therapeutics Inc. Held Shareholder Meeting
Reuters·01/16 21:58
REPARE SHAREHOLDERS APPROVE ACQUISITION BY XENOTHERAPEUTICS, INC.
Dow Jones·01/16 21:58
Press Release: Repare Shareholders Approve Acquisition by XenoTherapeutics, Inc.
TipRanks·12/29/2025 12:34
Repare Therapeutics Sells RP-3467 Program to Gilead
Reuters·12/29/2025 12:01
XenoTherapeutics to Acquire All Outstanding Shares of Repare Therapeutics
TipRanks·12/26/2025 21:05
Repare Sells Key Oncology Asset to Gilead, Lifts Expected Xeno Deal Payout
NASDAQ·12/24/2025 17:17
Wednesday Sector Leaders: Drugs, Biotechnology Stocks
Benzinga·12/24/2025 13:36
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.